Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing

David Loong is our senior consultant, novel modalities APAC, bioprocessing strategy. Previously, David held roles as a senior scientist in biotech startups encompassing cell & gene therapy process development services, mAb discovery, and preclinical development. He has an extensive track record providing contract research services as a senior research scientist at AMRI Global, and as a product custodian for API GMP manufacturing at GSK. He holds a Ph.D. in synthetic organic chemistry from the Australian National University and a BTech(Hons) from Massey University (NZ) specializing in chemistry and process engineering.

Josephine is the senior consultant for bioprocessing strategy at Merck, focusing on vaccine & mRNA modalities, where she stays on top of the market trends, fosters customer collaborations, supports innovation, leads marketing initiatives, generates publications, and transforms insights into sustainable business strategies. With over 14 years of international biopharma working experience, Josephine has accumulated practical industry knowledge and technical skills from various positions ranging from R&D, application, training, marketing, and strategy. Josephine obtained both bachelor's and master's degrees in bio-resources and agriculture from the National Taiwan University, focusing on protein & molecular science.